IP Verse

Engraftment Of Stem Cells With A Combination Of An Agent That Targets Stem Cells And Modulation Of Immunoregulatory Signaling

Patent No. EP3186395 (titled "Engraftment Of Stem Cells With A Combination Of An Agent That Targets Stem Cells And Modulation Of Immunoregulatory Signaling") was filed by The Board OF Trustees OF The Leland Stanford Junior University on Aug 26, 2015. The application was issued on Mar 29, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEMay 25, 2020-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3186395

THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Application Number
EP15835482A
Filing Date
Aug 26, 2015
Status
Patent Maintained As Amended
Feb 24, 2023
Publication Date
Mar 29, 2023
External Links
Slate, Register , Google Patents